首页> 美国卫生研究院文献>Open Forum Infectious Diseases >Are We Now Well Prepared for Another Major Visceral Leishmaniasis Epidemic in Sudan?
【2h】

Are We Now Well Prepared for Another Major Visceral Leishmaniasis Epidemic in Sudan?

机译:我们现在是否已为苏丹另一次主要内脏利什曼病流行做好准备?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To minimize the chance for future visceral leishmaniasis (VL) epidemics such as the 1988–1991 epidemic in Sudan, several VL detection tools have been introduced. There are many VL diagnostics with excellent sensitivities, specificities, and ease of use reported. However, additional test characteristics should be considered for use in the detection of future VL epidemics. The potential for local production or uninterrupted availability, low production and application costs, and stability at ≥45°C are of the utmost importance. Of the antibody-, antigen-, or DNA-based methods introduced, only a liquid direct agglutination test (LQ-DAT) remains in routine use. The LQ-DAT test may be the ideal diagnostic for detection of VL epidemics due to its low cost ($0.50/patient), stability under frequent and long-duration electric failures, and high level of reproducibility. The improved reliability for VL detection achieved locally through incorporating autochthonous L. donovani strains in antigen processing and precluding toxicants in test execution provides optimal sensitivity and safety for routine and mass application.
机译:为了将未来内脏利什曼病(VL)的流行(例如1988-1991年苏丹流行)的可能性降到最低,已引入了几种VL检测工具。据报道,许多VL诊断剂具有出色的敏感性,特异性和易用性。但是,应考虑使用其他测试特征来检测未来的VL流行病。本地生产或不间断可用性的潜力,较低的生产和应用成本以及≥45°C的稳定性至关重要。在引入的基于抗体,抗原或DNA的方法中,常规使用中仅保留液体直接凝集试验(LQ-DAT)。 LQ-DAT测试成本低(每位患者$ 0.50),在频繁和长期的电气故障下稳定且可重复性高,因此可能是检测VL流行病的理想诊断方法。通过在抗原加工中掺入土生的L. donovani菌株,并在测试执行中排除有毒物质,可以提高局部VL检测的可靠性,从而为常规和大规模应用提供了最佳的灵敏度和安全性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号